Lv31
390 积分 2021-08-30 加入
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
11小时前
已完结
T cell dynamics with neoadjuvant immunotherapy in head and neck cancer
12小时前
已完结
GPR34 is a metabolic immune checkpoint for ILC1-mediated antitumor immunity
2个月前
已完结
EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications
2个月前
已完结
CH7233163 Overcomes Osimertinib-Resistant EGFR-Del19/T790M/C797S Mutation
2个月前
已完结
Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors
2个月前
已完结
Cadonilimab: First Approval
2个月前
已完结
Tackling Osimertinib Resistance in EGFR-Mutant Non–Small Cell Lung Cancer
3个月前
已完结
Unveiling the Landscape of Uncommon EGFR Mutations in NSCLC-A Systematic Review
3个月前
已完结
Perioperative Treatment Strategies in EGFR-Mutant Early-Stage NSCLC: Current Evidence and Future Challenges
3个月前
已完结
皖公网安备34019202002308
